Microsoft Discovery became generally available on June 2 for organizations building governed R&D workflows. The platform connects specialized agents, scientific knowledge, simulation tools, validation data, and a new local preview app for researchers.
Life-science AI is moving from literature help toward executable research workflows. OpenAI says GPT-Rosalind reached 27.5% on MedChemBench, 21.6% on GeneBench, and 63.2% on LabWorkBench.
An AI system that assesses burn-wound healing potential in roughly 20 to 25 seconds has cleared a key US regulatory gate. Spectral AI can now begin commercial distribution of DeepView for burn centers, trauma centers, and emergency departments.
ZOZO’s ppf-contact-solver brings a production-grade cloth and soft-body contact engine into the open. The headline number is more than 180 million contacts in one scene, plus Blender support and an Apache 2.0 license.
An OpenAI general-purpose reasoning model has independently solved the planar unit distance problem — a famous open geometry question posed by Paul Erdős in 1946. External mathematicians verified the proof, marking the first time AI has autonomously solved a major open problem in mathematics.
An OpenAI general-purpose reasoning model independently disproved the Erdős unit distance conjecture — a central problem in discrete geometry open since 1946. This marks the first time in history that an AI has autonomously solved a prominent open math problem, verified by independent mathematicians including Princeton's Noga Alon.
Google DeepMind unveiled Gemini for Science at I/O 2026, a suite of experimental AI tools designed to help scientists explore hypotheses, validate work at scale, and analyze scientific literature.
Penn researchers demonstrated optical signal switching using exciton-polaritons — hybrid light-matter particles — consuming roughly 4 femtojoules per operation. The breakthrough removes a key obstacle to fully optical AI inference hardware.
Google DeepMind unveiled an AI Co-Mathematician system — a multi-agent Gemini-based framework scoring 48% on FrontierMath Tier 4, the highest ever for any AI. AlphaEvolve improved lower bounds on five Ramsey numbers, including R(3,13) whose previous record had stood for 11 years.
The FDA has launched a first-of-its-kind pilot using cloud-based causal AI to shorten drug and medical device clinical trial timelines by 20–40%. FDA Chief AI Officer Jeremy Walsh says the approach could also accelerate regulatory approval timelines.
Isomorphic Labs, the AI drug discovery company founded by DeepMind's Demis Hassabis, has raised $2.1 billion in Series B funding led by Thrive Capital. The round includes Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund.
UCLA researchers have identified DDL-920, the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice. The findings, published in Nature Communications, could transform stroke recovery into a pharmacological option.